1. Home
  2. PL vs SYRE Comparison

PL vs SYRE Comparison

Compare PL & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Labs PBC

PL

Planet Labs PBC

N/A

Current Price

$23.70

Market Cap

7.7B

Sector

Industrials

ML Signal

N/A

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

N/A

Current Price

$102.74

Market Cap

8.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PL
SYRE
Founded
2010
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
8.5B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
PL
SYRE
Price
$23.70
$102.74
Analyst Decision
Buy
Strong Buy
Analyst Count
12
12
Target Price
$27.64
$85.08
AVG Volume (30 Days)
6.7M
942.6K
Earning Date
06-03-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$307,727,000.00
N/A
Revenue This Year
$42.29
N/A
Revenue Next Year
$30.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.94
N/A
52 Week Low
$6.10
$14.51
52 Week High
$51.72
$108.14

Technical Indicators

Market Signals
Indicator
PL
SYRE
Relative Strength Index (RSI) 47.53 55.31
Support Level $19.57 $92.37
Resistance Level $27.57 $104.07
Average True Range (ATR) 1.40 5.63
MACD 0.73 -0.22
Stochastic Oscillator 81.92 63.06

Price Performance

Historical Comparison
PL
SYRE

About PL Planet Labs PBC

Planet Labs PBC is an Earth-imaging company. It uses space to help life on Earth by imaging the world every day and making change visible, accessible, and actionable. Its platform includes imagery, insights, and machine learning that empower companies, governments, and communities around the world to make timely decisions about the evolving world. Its solutions are Broad Area Management. Its products are Planet Monitoring, Planet Tasking, Planet Analytic Feeds, Planetary Variables, Planet Basemaps, Planet Insights, and Platform Pricing. The group provides solutions to the Agriculture Science Program, Energy & Infrastructure, Forestry & Land Use, Mapping, Sustainability, Maritime, Civil Government, U.S. State and Local, Europe, Planet Federal, Defense & Intelligence, and Armed Services.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: